Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 328Lung Neoplasms 158Pancreatic Neoplasms 30Adenocarcinoma of Lung 27Colorectal Neoplasms 26Neoplasms 24Small Cell Lung Carcinoma 21Breast Neoplasms 17Neoplasm Metastasis 15Mesothelioma, Malignant 14Ovarian Neoplasms 12Adenocarcinoma, Bronchiolo-Alveolar 12Mesothelioma 10Stomach Neoplasms 9Colonic Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Carcinoma 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Sarcoma 7Prostatic Neoplasms 7Head and Neck Neoplasms 7Rectal Neoplasms 6Non-Squamous Non-Small Cell Lung Cancer 6Melanoma 6Lymphoma, Non-Hodgkin 6Esophageal Neoplasms 6Lymphoma 5Thoracic Neoplasms 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4

Interventions

Gemcitabine 2Docetaxel 2Carboplatin 2iniparib 1bleomycin A6 1apatorsen 1Pemetrexed 1Injections 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Squamous Cell Lung Cancer × Gemcitabine × Thoracic × Clear all
NCT02423590 2017-08-22

Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers

Queen Mary University of London

Phase 2 Unknown
140 enrolled
Thoracic

Squamous Cell Lung Cancer

NCT01082549 2016-03-17

ECLIPSE

Sanofi

Phase 3 Completed
780 enrolled
Thoracic

Squamous Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡